SCHEMBL7575997

SCHEMBL7575997

Nc1nc2c(ncn2CCC(=O)NCc2ccco2)c(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TK1 P04183 1/20 0.51
HPRT1 P00492 8/20 0.48
PNP P00491 6/20 0.48
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
RECQL P46063 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
EDNRA P25101 1/20 0.45
HTR2A P28223 1/20 0.45
BLM P54132 1/20 0.45
HBB P68871 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7574667 0.82 PNP (0.52) TK1HPRT1PNPKDM4EPOLB
SCHEMBL7567095 0.80 TK1 (0.60) TK1HPRT1PNPRECQLUSP2
SCHEMBL4964313 0.80 PNP (0.66) TK1PNPALDH1A1KDM4ERECQL
SCHEMBL7575116 0.79 TK1 (0.59) TK1HPRT1PNPRECQLUSP2
SCHEMBL7570078 0.79 TK1 (0.65) TK1HPRT1PNPALDH1A1MEN1
SCHEMBL7576803 0.78 TK1 (0.60) TK1HPRT1PNP
SCHEMBL7982329 0.78 TK1 (0.57) TK1HPRT1PNPRECQLUSP2
SCHEMBL7568100 0.77 TDP1 (0.56) TK1ALDH1A1MEN1POLBKMT2A
SCHEMBL7570457 0.77 TK1 (0.56) TK1HPRT1PNPALDH1A1MEN1
SCHEMBL7980835 0.76 HPRT1 (0.50) TK1HPRT1PNPRECQLUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297226-B1 TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE NEOTHERAPEUTICS, INC. 2001-10-02 US claimed
EP-1237890-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES Neotherapeutics, Inc. (US) 2002-09-11 EP disclosed
US-6297226-B1 TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE NEOTHERAPEUTICS, INC. 2001-10-02 US disclosed
WO-2001029039-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES NEOTHERAPEUTICS, INC. (US) 2001-04-26 WO disclosed